
Biotech ETFs: XBI vs. IBB — Equal-Weight Innovation vs. Cap-Weighted Leaders
Biotech is a portfolio of binary events: FDA approval is the gate, and the PDUFA date is when the lottery is drawn. XBI equal-weights a bet on broad innovation; IBB cap-weights a bet on incumbent leaders. Neither logic is wrong — you're choosing which bet to make.

































